Chapters

Transcript

Video

Please discuss the two phases of the CAHtalyst trial in which you compared the placebo group with the crinecerfont arm, and the ability to maintain a down-titrated more physiological glucocorticoid dose.

Please discuss the two phases of the CAHtalyst trial in which you compared the placebo group with the crinecerfont arm, and the ability to maintain a down-titrated more physiological glucocorticoid dose.


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Richard Auchus, MD, PhD

Richard Auchus, MD, PhD

Professor of Pharmacology and Internal Medicine
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan School of Medicine
Ann Arbor, Michigan